Artia Global Partners LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Artia Global Partners LP disclosed 48 US equity positions worth $568.3m in its Q3 2025 13F filing. The largest position was INSM at 18.6% of the reported book, followed by ARGX and SLNOEUR. Against the Q2 2025 filing, it opened 17 new positions, added to 11 and reduced 4 among the top 48 holdings.
What did Artia Global Partners LP own in Q3 2025? Top 48 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 18.6% | $105.4m | 732,212 | -3% | reduced |
| 2 | ARGX ARGENX SE | Healthcare | 10.2% | $57.8m | 78,311 | 0% | held |
| 3 | SLNOEUR SOLENO THERAPEUTICS INC | 8.0% | $45.4m | 672,176 | 36% | added | |
| 4 | VRNA VERONA PHARMA PLC | 7.1% | $40.4m | 379,004 | -59% | reduced | |
| 5 | QURE UNIQURE NV | 6.8% | $38.5m | 658,839 | – | new | |
| 6 | MERUS N V | 4.9% | $27.9m | 296,750 | 0% | held | |
| 7 | PROSHARES TR II | 4.4% | $24.8m | 537,372 | – | new | |
| 8 | LLY ELI LILLY & CO | Healthcare | 3.9% | $21.9m | 28,700 | -7% | reduced |
| 9 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 3.8% | $21.6m | 55,100 | 1152% | added |
| 10 | ABVX ABIVAX SA | 3.4% | $19.1m | 225,453 | – | new | |
| 11 | TRVI TREVI THERAPEUTICS INC | Healthcare | 3.2% | $18.3m | 1,999,702 | 52% | added |
| 12 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 3.1% | $17.9m | 183,200 | 18% | added |
| 13 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 2.8% | $15.8m | 34,570 | 65% | added |
| 14 | DGX QUEST DIAGNOSTICS INC | Healthcare | 2.7% | $15.6m | 81,717 | 0% | held |
| 15 | AZN ASTRAZENECA PLC | Healthcare | 2.6% | $14.6m | 190,752 | 0% | held |
| 16 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.6% | $8.9m | 628,367 | 98% | added |
| 17 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.1% | $6.0m | 10,671 | 0% | held |
| 18 | NEWAMSTERDAM PHARMA COMPANY | 1.0% | $5.5m | 194,838 | 613% | added | |
| 19 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.9% | $4.9m | 104,190 | 0% | held |
| 20 | RNAGBP AVIDITY BIOSCIENCES INC | 0.8% | $4.8m | 110,100 | 218% | added | |
| 21 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.8% | $4.3m | 108,723 | – | new |
| 22 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.7% | $3.9m | 60,176 | – | new |
| 23 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.7% | $3.8m | 146,179 | 52% | added |
| 24 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.6% | $3.6m | 96,285 | -24% | reduced |
| 25 | ABBV ABBVIE INC | Healthcare | 0.6% | $3.4m | 14,500 | 0% | held |
| 26 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.6% | $3.3m | 57,999 | – | new |
| 27 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.6% | $3.2m | 133,291 | – | new | |
| 28 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.4% | $2.4m | 12,240 | 0% | held |
| 29 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.4% | $2.1m | 56,600 | 38% | added |
| 30 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 0.4% | $2.1m | 5,000 | 0% | held |
| 31 | TGTX TG THERAPEUTICS INC | Healthcare | 0.3% | $2.0m | 54,515 | 0% | held |
| 32 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 0.3% | $1.9m | 64,502 | 54% | added |
| 33 | RAPP RAPPORT THERAPEUTICS INC | 0.3% | $1.9m | 64,608 | – | new | |
| 34 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.3% | $1.6m | 141,061 | – | new |
| 35 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.3% | $1.6m | 40,000 | 0% | held |
| 36 | IREN IREN LIMITED | Financial Services | 0.3% | $1.6m | 33,200 | – | new |
| 37 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.3% | $1.5m | 22,951 | 0% | held |
| 38 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 0.2% | $1.2m | 41,600 | – | new |
| 39 | BHVN BIOHAVEN LTD | Healthcare | 0.2% | $1.2m | 80,000 | 0% | held |
| 40 | KINIKSA PHARMACEUTICALS INTL | 0.2% | $1.1m | 29,200 | 0% | held | |
| 41 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.2% | $1.1m | 20,400 | – | new |
| 42 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.2% | $979.2k | 475,361 | 0% | held |
| 43 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.2% | $865.2k | 44,900 | – | new |
| 44 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.1% | $738.5k | 30,900 | 0% | held |
| 45 | MRNA MODERNA INC | Healthcare | 0.1% | $614.8k | 23,800 | – | new |
| 46 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.1% | $506.1k | 41,555 | – | new | |
| 47 | ATYR ATYR PHARMA INC | Healthcare | 0.0% | $268.6k | 372,276 | – | new |
| 48 | ALEC ALECTOR INC | Healthcare | 0.0% | $210.2k | 71,029 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.